Seniors who took low-dose aspirin daily had similar odds of developing mild cognitive impairment, dementia or Alzheimer's disease after nearly five years, compared with those who didn't take aspirin, researchers reported in Neurology. The findings, based on data involving more than 19,000 older adults without cardiovascular disease or dementia, also showed similar rates of cognitive decline between both groups.
Daily low-dose aspirin intake may not protect against MCI, dementia
Sign up for SNMMI SmartBrief
Nuclear medicine and molecular imaging news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.